ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 130 filers reported holding ARRAY BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $24,947,000 | +30.3% | 538,490 | -31.4% | 0.01% | +22.2% |
| Q1 2019 | $19,148,000 | +433.1% | 785,480 | +211.6% | 0.01% | +350.0% |
| Q4 2018 | $3,592,000 | -2.7% | 252,047 | +3.8% | 0.00% | +100.0% |
| Q3 2018 | $3,690,000 | +34.9% | 242,727 | +48.9% | 0.00% | 0.0% |
| Q2 2018 | $2,736,000 | -27.2% | 162,995 | -29.2% | 0.00% | -50.0% |
| Q1 2018 | $3,759,000 | +52.9% | 230,326 | +19.9% | 0.00% | +100.0% |
| Q4 2017 | $2,459,000 | +61.5% | 192,142 | +55.2% | 0.00% | 0.0% |
| Q3 2017 | $1,523,000 | – | 123,826 | +95150.8% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 130 | -40.9% | 0.00% | – |
| Q2 2014 | $1,000 | -97.8% | 220 | -97.0% | 0.00% | – |
| Q3 2013 | $45,000 | +36.4% | 7,279 | 0.0% | 0.00% | – |
| Q2 2013 | $33,000 | – | 7,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |